Effects of Vitamin D-3 Supplementation During Pregnancy and Lactation on Maternal and Infant Biomarkers of Environmental Enteric Dysfunction, Systemic Inflammation, and Growth: A Secondary Analysis of a Randomized Controlled Trial
The Journal of Nutrition · 2024
DOI: 10.1016/j.tjnut.2024.08.032 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Nutrition, 2024. Verfasst von Jacqueline M Lauer und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, Sargent College of Health & Rehabilitation Sciences, Boston University, Boston, Massachusetts, United States; Division…. Hauptthemen laut MEDLINE: Pregnancy, Biomarkers, Cholecalciferol, Dietary Supplements. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: FIC NIH HHS, NIDDK NIH HHS, NICHD NIH HHS.
Themen: Stillen
Abstract (Originalsprache)
BACKGROUND: Environmental enteric dysfunction (EED) is an acquired, subclinical state of intestinal inflammation common in children and adults in low-income and middle-income countries. Although vitamin D-3 supplementation has purported anti-inflammatory properties, its ability to ameliorate biomarkers of EED remains unclear. OBJECTIVES: This study aimed to examine the effects of maternal vitamin D-3 supplementation during pregnancy and lactation on biomarkers of EED, systemic inflammation, and growth in women living with HIV and their infants in Dar es Salaam, Tanzania. METHODS: We conducted subgroup analyses among randomly selected mothers (n = 720) and infants (n = 365 at 6 wk of age, and n = 266 at 6 mo of age) who participated in a randomized, triple-blind, placebo-controlled trial of daily maternal 3000 IU vitamin D-3 supplementation from the second trimester of pregnancy until 1 y postpartum. Biomarkers of EED (soluble CD14 and intestinal fatty acid-binding protein), systemic inflammation (C-reactive protein and α1-acid glycoprotein), and growth factors (insulin-like growth factor 1 and fibroblast growth factor 21) were measured via the Micronutrient and Environmental Enteric Dysfunction Assessment Tool. Anti-flagellin and anti-lipopolysaccharide immunoglobulins were measured via enzyme-linked immunosorbent assay. Comparisons by randomized treatment arm were performed using ordinary least squares regression models with log2-transformed biomarkers. RESULTS: At 32 wk of gestation, intestinal fatty acid-binding protein (β: -0.19; P = 0.03) and α1-acid glycoprotein (β:-0.11; P = 0.04) were significantly lower in mothers in the vitamin D-3 group than those in mothers in the placebo group. At 6 wk of age, insulin-like growth factor 1 (β:-0.31; P = 0.03) was significantly lower in infants whose mothers were in the vitamin D-3 group than that in infants whose mothers were in the placebo group. CONCLUSIONS: Vitamin D-3 supplementation during pregnancy and lactation reduced selected EED and systemic inflammation biomarkers among women living with HIV. While the effects of maternal vitamin D-3 supplementation do not appear to extend to infants, there may be an effect on growth factors. This trial was registered at clinicaltrials.gov as NCT02305927 (https://clinicaltrials.gov/study/NCT02305927).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Sciences, Sargent College of Health & Rehabilitation Sciences, Boston University, Boston, Massachusetts, United States; Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hosp…
- Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States.
- Africa Academy for Public Health, Dar es Salaam, Tanzania.
- Management and Development for Health, Dar es Salaam, Tanzania.
- Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; National Institute for Medical Research, Dar es Salaam, Tanzania.
- Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, Massachusetts, United States; Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, Boston…
Förderung
- FIC NIH HHS
- NIDDK NIH HHS
- NICHD NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Institute of Child Health and Human Development
Zitieren
APA
Lauer, J. M., Kirby, M. A., Muhihi, A., Ulenga, N., Aboud, S., Liu, E., Choy, R. K., Arndt, M. B., Kou, J., Fawzi, W. W., Gewirtz, A. T., Sudfeld, C. R., Manji, K. P., & Duggan, C. P. (2024). Effects of Vitamin D-3 Supplementation During Pregnancy and Lactation on Maternal and Infant Biomarkers of Environmental Enteric Dysfunction, Systemic Inflammation, and Growth: A Secondary Analysis of a Randomized Controlled Trial. The Journal of Nutrition. https://doi.org/10.1016/j.tjnut.2024.08.032
Vancouver
Lauer JM, Kirby MA, Muhihi A, Ulenga N, Aboud S, Liu E, et al. Effects of Vitamin D-3 Supplementation During Pregnancy and Lactation on Maternal and Infant Biomarkers of Environmental Enteric Dysfunction, Systemic Inflammation, and Growth: A Secondary Analysis of a Randomized Controlled Trial. The Journal of Nutrition. 2024. doi:10.1016/j.tjnut.2024.08.032
BibTeX
@article{Lauer2024,
author = {Lauer, Jacqueline M and Kirby, Miles A and Muhihi, Alfa and Ulenga, Nzovu and Aboud, Said and Liu, Enju and Choy, Robert Km and Arndt, Michael B and Kou, Jianqun and Fawzi, Wafaie W and Gewirtz, Andrew T and Sudfeld, Christopher R and Manji, Karim P and Duggan, Christopher P},
title = {Effects of Vitamin D-3 Supplementation During Pregnancy and Lactation on Maternal and Infant Biomarkers of Environmental Enteric Dysfunction, Systemic Inflammation, and Growth: A Secondary Analysis of a Randomized Controlled Trial},
journal = {The Journal of Nutrition},
year = {2024},
doi = {10.1016/j.tjnut.2024.08.032}
}
EUVIMED